These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1735613)

  • 41. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
    Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
    Aoki T; Tashiro K; Miyatake S; Kinashi T; Nakano T; Oda Y; Kikuchi H; Honjo T
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3850-4. PubMed ID: 1570303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential IL-12 responsiveness of T cells but not of NK cells from tumor-bearing mice in IL-12-responsive versus -unresponsive tumor models.
    Iwasaki M; Yu WG; Uekusa Y; Nakajima C; Yang YF; Gao P; Wijesuriya R; Fujiwara H; Hamaoka T
    Int Immunol; 2000 May; 12(5):701-9. PubMed ID: 10784616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Memory type 2 helper T cells induce long-lasting antitumor immunity by activating natural killer cells.
    Kitajima M; Ito T; Tumes DJ; Endo Y; Onodera A; Hashimoto K; Motohashi S; Yamashita M; Nishimura T; Ziegler SF; Nakayama T
    Cancer Res; 2011 Jul; 71(14):4790-8. PubMed ID: 21646476
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
    Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
    Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
    Brunda MJ; Luistro L; Warrier RR; Wright RB; Hubbard BR; Murphy M; Wolf SF; Gately MK
    J Exp Med; 1993 Oct; 178(4):1223-30. PubMed ID: 8104230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-10 reduces natural killer sensitivity and downregulates MHC class I expression on H-ras-transformed cells.
    Tsuruma T; Yagihashi A; Torigoe T; Sato N; Kikuchi K; Watanabe N; Hirata K
    Cell Immunol; 1998 Mar; 184(2):121-8. PubMed ID: 9630838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
    Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phencyclidine exposure alters in vitro cellular immune response parameters associated with host defense.
    Thomas PT; House RV; Bhargava HN
    Life Sci; 1993; 53(18):1417-27. PubMed ID: 8231630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity.
    Fakhrai H; Shawler DL; Gjerset R; Naviaux RK; Koziol J; Royston I; Sobol RE
    Hum Gene Ther; 1995 May; 6(5):591-601. PubMed ID: 7578396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
    Voronov E; Weinstein Y; Benharroch D; Cagnano E; Ofir R; Dobkin M; White RM; Zoller M; Barak V; Segal S; Apte RN
    Cancer Res; 1999 Mar; 59(5):1029-35. PubMed ID: 10070959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin 7 induces CD4+ T cell-dependent tumor rejection.
    Hock H; Dorsch M; Diamantstein T; Blankenstein T
    J Exp Med; 1991 Dec; 174(6):1291-8. PubMed ID: 1683890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Local and systemic immune response to inactivated Candida albicans in mice.
    Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P
    Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The induction of IL-6 and gelatinase B by IL-1 in mouse cell lines transformed with bovine papillomavirus: decreased production in tumorigenic cells.
    Fuse A; Simizu B; Van Ranst M; Opdenakker G; Van Damme J
    Lymphokine Cytokine Res; 1992 Aug; 11(4):215-20. PubMed ID: 1330001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response.
    Sinha P; Clements VK; Bunt SK; Albelda SM; Ostrand-Rosenberg S
    J Immunol; 2007 Jul; 179(2):977-83. PubMed ID: 17617589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NK cells mediate increase of phagocytic activity but not of proinflammatory cytokine (interleukin-6 [IL-6], tumor necrosis factor alpha, and IL-12) production elicited in splenic macrophages by tilorone treatment of mice during acute systemic candidiasis.
    Gaforio JJ; Ortega E; Algarra I; Serrano MJ; Alvarez de Cienfuegos G
    Clin Diagn Lab Immunol; 2002 Nov; 9(6):1282-94. PubMed ID: 12414762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions.
    Stoppacciaro A; Forni G; Colombo MP
    Folia Biol (Praha); 1994; 40(1-2):89-99. PubMed ID: 7525363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dendritic cells, macrophages, NK and CD8
    Lucinda N; Figueiredo MM; Pessoa NL; Santos BS; Lima GK; Freitas AM; Machado AM; Kroon EG; Antonelli LR; Campos MA
    Virol J; 2017 Feb; 14(1):37. PubMed ID: 28222752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice.
    Shimizu K; Goto A; Fukui M; Taniguchi M; Fujii S
    J Immunol; 2007 Mar; 178(5):2853-61. PubMed ID: 17312129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.